vs
Side-by-side financial comparison of Cytosorbents Corp (CTSO) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $8.7M, roughly 1.1× SWK Holdings Corp). On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -29.7%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -12.5%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
CTSO vs SWKH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $8.7M |
| Net Profit | $-5.5M | $-19.4M |
| Gross Margin | 73.7% | — |
| Operating Margin | -47.5% | 9.9% |
| Net Margin | -59.5% | — |
| Revenue YoY | 0.9% | -29.7% |
| Net Profit YoY | 27.4% | -430.2% |
| EPS (diluted) | $-0.09 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $8.7M | ||
| Q3 25 | $9.5M | $10.9M | ||
| Q2 25 | $9.6M | $10.1M | ||
| Q1 25 | $8.7M | $11.8M | ||
| Q4 24 | $9.2M | $12.4M | ||
| Q3 24 | $8.6M | $10.4M | ||
| Q2 24 | $8.8M | $10.8M | ||
| Q1 24 | $9.0M | $11.4M |
| Q4 25 | $-5.5M | $-19.4M | ||
| Q3 25 | $-3.2M | $8.8M | ||
| Q2 25 | $1.9M | $3.5M | ||
| Q1 25 | $-1.5M | $4.5M | ||
| Q4 24 | $-7.6M | $5.9M | ||
| Q3 24 | $-2.8M | $3.5M | ||
| Q2 24 | $-4.3M | $3.7M | ||
| Q1 24 | $-6.1M | $468.0K |
| Q4 25 | 73.7% | — | ||
| Q3 25 | 70.3% | — | ||
| Q2 25 | 70.9% | — | ||
| Q1 25 | 71.1% | — | ||
| Q4 24 | 68.4% | — | ||
| Q3 24 | 61.0% | — | ||
| Q2 24 | 73.5% | — | ||
| Q1 24 | 76.5% | — |
| Q4 25 | -47.5% | 9.9% | ||
| Q3 25 | -30.2% | 61.3% | ||
| Q2 25 | -37.6% | 46.1% | ||
| Q1 25 | -44.5% | 68.6% | ||
| Q4 24 | -37.1% | 44.7% | ||
| Q3 24 | -56.1% | 39.2% | ||
| Q2 24 | -40.4% | 8.3% | ||
| Q1 24 | -51.8% | 9.5% |
| Q4 25 | -59.5% | — | ||
| Q3 25 | -33.4% | 80.7% | ||
| Q2 25 | 20.2% | 35.2% | ||
| Q1 25 | -16.9% | 38.4% | ||
| Q4 24 | -82.7% | 47.5% | ||
| Q3 24 | -32.1% | 33.3% | ||
| Q2 24 | -48.6% | 33.9% | ||
| Q1 24 | -67.7% | 4.1% |
| Q4 25 | $-0.09 | $-1.59 | ||
| Q3 25 | $-0.05 | $0.72 | ||
| Q2 25 | $0.03 | $0.29 | ||
| Q1 25 | $-0.02 | $0.37 | ||
| Q4 24 | $-0.14 | $0.47 | ||
| Q3 24 | $-0.05 | $0.28 | ||
| Q2 24 | $-0.08 | $0.30 | ||
| Q1 24 | $-0.11 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.2M | $42.8M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $5.9M | $235.1M |
| Total Assets | $44.2M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $42.8M | ||
| Q3 25 | $7.5M | $10.2M | ||
| Q2 25 | $10.2M | $8.0M | ||
| Q1 25 | $11.6M | $29.8M | ||
| Q4 24 | $3.3M | $5.9M | ||
| Q3 24 | $5.7M | $17.2M | ||
| Q2 24 | $8.5M | $5.5M | ||
| Q1 24 | $8.6M | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | $13.8M | $33.0M | ||
| Q2 24 | $13.7M | $33.0M | ||
| Q1 24 | $4.4M | $33.0M |
| Q4 25 | $5.9M | $235.1M | ||
| Q3 25 | $9.0M | $254.2M | ||
| Q2 25 | $11.6M | $246.5M | ||
| Q1 25 | $14.5M | $292.7M | ||
| Q4 24 | $11.1M | $288.7M | ||
| Q3 24 | $13.4M | $283.4M | ||
| Q2 24 | $17.4M | $282.8M | ||
| Q1 24 | $19.6M | $279.9M |
| Q4 25 | $44.2M | $272.4M | ||
| Q3 25 | $45.8M | $289.4M | ||
| Q2 25 | $48.0M | $285.7M | ||
| Q1 25 | $50.8M | $331.3M | ||
| Q4 24 | $47.4M | $332.2M | ||
| Q3 24 | $47.8M | $321.3M | ||
| Q2 24 | $53.4M | $321.0M | ||
| Q1 24 | $47.1M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | 1.03× | 0.12× | ||
| Q2 24 | 0.78× | 0.12× | ||
| Q1 24 | 0.23× | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $27.3M |
| Free Cash FlowOCF − Capex | $-4.9M | $26.8M |
| FCF MarginFCF / Revenue | -53.4% | 308.1% |
| Capex IntensityCapex / Revenue | 1.2% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $27.3M | ||
| Q3 25 | $-2.6M | $906.0K | ||
| Q2 25 | $-1.5M | $7.8M | ||
| Q1 25 | $-3.5M | $8.3M | ||
| Q4 24 | $-2.3M | $23.0M | ||
| Q3 24 | $-2.5M | $6.3M | ||
| Q2 24 | $-4.8M | $5.4M | ||
| Q1 24 | $-4.8M | $4.4M |
| Q4 25 | $-4.9M | $26.8M | ||
| Q3 25 | $-2.6M | $557.0K | ||
| Q2 25 | $-1.5M | $7.7M | ||
| Q1 25 | $-3.5M | $8.2M | ||
| Q4 24 | $-2.4M | $22.9M | ||
| Q3 24 | $-2.6M | $6.3M | ||
| Q2 24 | $-4.8M | $5.4M | ||
| Q1 24 | $-4.9M | — |
| Q4 25 | -53.4% | 308.1% | ||
| Q3 25 | -27.3% | 5.1% | ||
| Q2 25 | -16.1% | 77.0% | ||
| Q1 25 | -39.7% | 69.1% | ||
| Q4 24 | -26.3% | 185.3% | ||
| Q3 24 | -30.4% | 60.4% | ||
| Q2 24 | -54.4% | 49.7% | ||
| Q1 24 | -54.2% | — |
| Q4 25 | 1.2% | 5.9% | ||
| Q3 25 | 0.2% | 3.2% | ||
| Q2 25 | 0.4% | 0.6% | ||
| Q1 25 | 0.0% | 0.8% | ||
| Q4 24 | 0.8% | 1.1% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 0.5% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | -0.78× | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
